Picture of Accuray logo

ARAY Accuray News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapValue Trap

Accuray Inc reports results for the quarter ended in March - Earnings Summary

* Accuray Inc  ARAY.OQ  reported a quarterly adjusted loss
of 6
cents​​ per share for the quarter ended in March, lower than the
same quarter last year, when the company reported EPS of 1
cents.  The mean expectation of four analysts for the quarter
was for a loss of one cent per share. Wall Street expected
results to range from -3 cents tozero cents per share.
    * Revenue fell 14.3% to $101.13 million from a year ago;
analysts
expected $113.65 million. 
    * Accuray Inc shares had fallen by 13.8% this quarter and
lost 24.7% so far this year.

FORECAST CHANGES
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is  "buy."

Wall Street's median 12-month price target for Accuray Inc is
$8.00 
This summary was machine generated from LSEG data May 1 at 09:02
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.01          -0.06          Missed
 Dec. 31 2023      -0.05          -0.10          Missed
 Sep. 30 2023      -0.05          -0.03          Beat
 Jun. 30 2023      0.01           -0.03          Missed

Recent news on Accuray

See all news